A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
This is a multi-center, open-label, randomized, phase 2/3 trial of the bispecific antibody CTX-009 plus paclitaxel versus paclitaxel in patients with previously treated, unresectable advanced or metastatic biliary tract cancers.
Epistemonikos ID: 1a501612e8323a3fae2177b7fc121d85df44aa41
First added on: May 13, 2024